BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 16990195)

  • 41. Helicobacter pylori infection in pathogenesis of gastroesophageal reflux disease.
    Thor PJ; Błaut U
    J Physiol Pharmacol; 2006 Sep; 57 Suppl 3():81-90. PubMed ID: 17033107
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Control of gastric acid secretion in health and disease.
    Schubert ML; Peura DA
    Gastroenterology; 2008 Jun; 134(7):1842-60. PubMed ID: 18474247
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Helicobacter pylori and gastroesophageal reflux disease.
    Metz DC; Kroser JA
    Gastroenterol Clin North Am; 1999 Dec; 28(4):971-85, viii. PubMed ID: 10695012
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Systematic review: Rebound acid hypersecretion after therapy with proton pump inhibitors.
    Hunfeld NG; Geus WP; Kuipers EJ
    Aliment Pharmacol Ther; 2007 Jan; 25(1):39-46. PubMed ID: 17229219
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Guidelines in the medical treatment of Helicobacter pylori infection.
    Dzieniszewski J; Jarosz M
    J Physiol Pharmacol; 2006 Sep; 57 Suppl 3():143-54. PubMed ID: 17033112
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Therapy resistance of gastro-oesophageal reflux symptoms: acid reflux, non-acid reflux or no reflux].
    Bredenoord AJ; Smout AJ
    Ned Tijdschr Geneeskd; 2008 Nov; 152(47):2548-52. PubMed ID: 19174935
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Strong activation of PAR-2 receptors: a common trigger for the development of gastrointestinal adenocarcinomas?
    Olbe L
    Scand J Gastroenterol; 2007 Sep; 42(9):1133-7. PubMed ID: 17710682
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Gastric acid secretion in gastroesophageal reflex disease].
    Koyama S; Bamba T
    Nihon Rinsho; 2000 Sep; 58(9):1800-3. PubMed ID: 11004805
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Evidence-based medicine on the relationship between Helicobacter pylori and gastroesophageal reflux disease].
    Wang JY; Tu CT
    Zhonghua Yi Xue Za Zhi; 2006 Oct; 86(38):2667-9. PubMed ID: 17199972
    [No Abstract]   [Full Text] [Related]  

  • 50. [Gastroesophageal reflux disease and Helicobacter pylori].
    Prelipcean CC; Stanciu C
    Rev Med Chir Soc Med Nat Iasi; 2000; 104(2):7-9. PubMed ID: 12089994
    [No Abstract]   [Full Text] [Related]  

  • 51. Meta-analysis used to identify factors associated with the effectiveness of proton pump inhibitors against non-erosive reflux disease.
    Hiyama T; Matsuo K; Urabe Y; Fukuhara T; Tanaka S; Yoshihara M; Haruma K; Chayama K
    J Gastroenterol Hepatol; 2009 Aug; 24(8):1326-32. PubMed ID: 19702900
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Acid suppression therapy for Barrett's esophagus.
    Spechler SJ
    Eur J Surg Suppl; 2001; (586):78-81. PubMed ID: 11718531
    [No Abstract]   [Full Text] [Related]  

  • 53. Infections of the esophagus and the stomach.
    Quiding-Järbrink M; Bove M; Dahlén G
    Periodontol 2000; 2009 Feb; 49():166-78. PubMed ID: 19152533
    [No Abstract]   [Full Text] [Related]  

  • 54. [Night acid "bursting": treatment of patients with gastroesophageal reflux disease].
    Vasil'ev IuV; Beliaeva VS
    Eksp Klin Gastroenterol; 2007; (3):83-91. PubMed ID: 17937011
    [No Abstract]   [Full Text] [Related]  

  • 55. [Gastroesophageal reflux disease and Helicobacter pylori].
    Aruin II; Isakov VA
    Klin Med (Mosk); 2000; 78(10):62-8. PubMed ID: 11220906
    [No Abstract]   [Full Text] [Related]  

  • 56. Acid inhibition and gastroesophageal reflux disease.
    Sachs G
    Yale J Biol Med; 1999; 72(2-3):227-9. PubMed ID: 10780585
    [No Abstract]   [Full Text] [Related]  

  • 57. Helicobacter pylori and gastro-oesophageal reflux disease.
    Kountouras J; Zavos C; Chatzopoulos D; Katsinelos P
    Lancet; 2006 Sep; 368(9540):986; author reply 986-7. PubMed ID: 16980103
    [No Abstract]   [Full Text] [Related]  

  • 58. New guidelines for Helicobacter pylori: applying them to your practice.
    Nimish V
    Rev Gastroenterol Disord; 2007; 7(3):111-4. PubMed ID: 17928790
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Advances in pharmacologic treatment of gastroesophageal reflux disease].
    Nogueira de Rojas JR
    Rev Gastroenterol Mex; 2003 Nov; 68 Suppl 3():22-8. PubMed ID: 15146788
    [No Abstract]   [Full Text] [Related]  

  • 60. Gastroesophageal reflux-related chronic laryngitis: con.
    Vaezi MF
    Arch Otolaryngol Head Neck Surg; 2010 Sep; 136(9):908-9. PubMed ID: 20855684
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.